Nasdaq Jumps Over 300 Points Following Comments From Fed Chair Powell
U.S. stocks turned sharply higher toward the end of trading, following comments from Fed Chair Jerome Powell.
Why Leslie’s Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.
Crude Oil Rises Sharply; XPeng Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 25 points on Wednesday.
Aeglea Nosedives After Clinical Update On Investigational Candidate For Rare Metabolism Disease
Aeglea BioTherapeutics Inc (NASDAQ: AGLE) has appointed Jeffrey M. Goldberg as president, chief executive officer, and a board member, effective November 29, 2022.
Recap: Aeglea BioTherapeutics Q3 Earnings
Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Gainers
Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Wells Fargo Upgrades Aeglea BioTherapeutics to Overweight, Raises Price Target to $2
Wells Fargo analyst Yanan Zhu upgrades Aeglea BioTherapeutics (NASDAQ:AGLE) from Equal-Weight to Overweight and raises the price target from $1.5 to $2.